Fiserv to Present at Upcoming Investor Conferences
Get Alerts FISV Hot Sheet
Join SI Premium – FREE
MILWAUKEE, April 20, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology solutions, announced its participation in the following investor conferences in May.
Fiserv will present at the following conferences:
- J.P. Morgan 2026 Global Technology, Media, and Communications Conference (Mike Lyons, CEO)
- 3:35 p.m. ET on May 19
- Bernstein Strategic Decisions Conference (Mike Lyons, CEO)
- 3:30 p.m. on May 28
Live webcasts and archived replays will be available on the investor relations section of the Fiserv website at investors.fiserv.com.
About Fiserv
Fiserv, Inc. (NASDAQ: FISV), a Fortune 500 company, moves more than money. As a global leader in payments and financial technology, the company helps clients achieve best-in-class results through a commitment to innovation and excellence in areas including account processing and digital banking solutions; card issuer processing and network services; payments; e-commerce; merchant acquiring and processing; and Clover®, the world’s smartest point-of-sale system and business management platform. Fiserv is a member of the S&P 500® Index and one of TIME Magazine’s Most Influential Companies™. Visit fiserv.com and follow on social media for more information and the latest company news.
For more information contact:
| Media Relations: Melissa Moritz Vice President, External Communications Fiserv, Inc. +1 516-410-1188 [email protected] | Investor Relations: Walter Pritchard Senior Vice President, Investor Relations Fiserv, Inc. [email protected] |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Island Passage Exploration and Isina Resource Holdings Announce Land Access and Compensation Payments of 200,000 Kina made to customary landowners from work conducted on the EL02 Project Bougainville
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Walk to Earn? AIXAlpha Launches a New Daily Investment Program That Feels Just as Simple
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
JPMorgan, Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share